Essa Pharma considering offering debt securities in next 25 months

By Wendy Van Sickle

Columbus, Ohio, Dec. 15 – Essa Pharma Inc. may offer new debt securities in the United States and Canada over the next 25 months, according to a press release.

The company said it filed a prospectus with regulatory authorities in Canada to issue up to $100 million of debt securities, common shares, warrants to purchase common shares, units of common shares and warrants, and subscription receipts exercisable for common shares, warrants or units.

The Vancouver, B.C.-based pharmaceutical company focuses on developing therapies for the treatment of castration-resistant prostate cancer.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.